Skip to Main content Skip to Navigation
Journal articles

Target gene sequencing to define the susceptibility of Neisseria meningitidis to ciprofloxacin.

Eva Hong 1 Sara Thulin Hedberg 2 Raquel Abad 3 Cecilia Fazio 4 Rocío Enríquez 3 Ala-Eddine Deghmane 1 Keith Jolley 5 Paola Stefanelli 4 Magnus Unemo 2 Julio Vazquez 3 Frédéric Veyrier 1 Muhamed-Kheir Taha 1, *
* Corresponding author
1 CNR - Centre National de Référence des Méningocoques-Infections Bactériennes Invasives
2 Department of Laboratory Medicine, Microbiology, Örebro University Hospital
3 ISC - Instituto de Salud Carlos III [Madrid]
4 Department of Infectious, Parasitic and Immune-Mediated Diseases [Rome]
5 University of Oxford [Oxford]
Abstract : Meningococcal gyrA gene sequence data, MICs, and mouse infection were used to define the ciprofloxacin breakpoint for Neisseria meningitidis. Residue T91 or D95 of GyrA was altered in all meningococcal isolates with MICs of ≥ 0.064 μg/ml but not among isolates with MICs of ≤ 0.032 μg/ml. Experimental infection of ciprofloxacin-treated mice showed slower bacterial clearance when GyrA was altered. These data suggest a MIC of ≥ 0.064 μg/ml as the ciprofloxacin breakpoint for meningococci and argue for the molecular detection of ciprofloxacin resistance.
Document type :
Journal articles
Complete list of metadatas
https://hal-pasteur.archives-ouvertes.fr/pasteur-02089320
Contributor : Marie Martin <>
Submitted on : Wednesday, April 3, 2019 - 4:09:34 PM
Last modification on : Wednesday, October 14, 2020 - 4:15:00 AM

Links full text

pubmedcentral

Identifiers

Collections

PASTEUR

Citation

Eva Hong, Sara Thulin Hedberg, Raquel Abad, Cecilia Fazio, Rocío Enríquez, et al.. Target gene sequencing to define the susceptibility of Neisseria meningitidis to ciprofloxacin.. Antimicrobial Agents and Chemotherapy, American Society for Microbiology, 2013, 57 (4), pp.1961-1964. ⟨10.1128/AAC.02184-12⟩. ⟨pasteur-02089320⟩

Export

BibTeX TEI DC DCterms EndNote

Share

Metrics

Record views

90